(Q39519018)

English

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis

scientific article published on 24 November 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 September 2017

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis (English)

1 reference

Europe PubMed Central

12 September 2017

1 reference

based on heuristic

inferred from title

meglumine antimoniate

1 reference

based on heuristic

inferred from title

author name string

Pouran Layegh

1

1 reference

Europe PubMed Central

12 September 2017

Omid Rajabi

2

1 reference

Europe PubMed Central

12 September 2017

Mahmoud Reza Jafari

3

1 reference

Europe PubMed Central

12 September 2017

Parisa Emamgholi Tabar Malekshah

4

1 reference

Europe PubMed Central

12 September 2017

Toktam Moghiman

5

1 reference

Europe PubMed Central

12 September 2017

Hami Ashraf

6

1 reference

Europe PubMed Central

12 September 2017

Roshanak Salari

7

1 reference

Europe PubMed Central

12 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

24 November 2011

1 reference

Europe PubMed Central

12 September 2017

Journal of parasitology research

1 reference

Europe PubMed Central

12 September 2017

2011

1 reference

Europe PubMed Central

12 September 2017

656523

1 reference

Europe PubMed Central

12 September 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2011

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

0 references

Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Unresponsiveness to Glucantime treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Production and characterization of stable amphotericin-resistant amastigotes and promastigotes of Leishmania mexicana.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Successful liposomal amphotericin B treatment of Leishmania braziliensis cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Chemotherapy of leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Amphotericin B preparations: a maximum tolerated dose in severe invasive fungal infections?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Cutaneous leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Efficacious topical treatment for murine cutaneous leishmaniasis with ethanolic formulations of amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

12 September 2017

Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

14 September 2017

Evaluation of PCR assay in diagnosis and identification of cutaneous leishmaniasis: a comparison with the parasitological methods.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Atypical multifocal cutaneous leishmaniasis in an immunocompetent patient treated by liposomal amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Successful treatment of cutaneous leishmaniasis with lipid formulations of amphotericin B in two immunocompromised patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Topical treatment of persistent cutaneous leishmaniasis with ethanolic lipid amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Efficacious topical treatment for human cutaneous leishmaniasis with ethanolic lipid amphotericin B.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

A single high dose treatment of kala-azar with Ambisome (amphotericin B lipid complex): a pilot study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Use of amphotericin B in drug-resistant cases of visceral leishmaniasis in north Bihar, India.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3228299

21 August 2018

Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/22174993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel method for the preparation of liposomes: freeze drying of monophase solutions

1 reference

https://pubmed.ncbi.nlm.nih.gov/22174993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Topical amphotericin B for cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/22174993

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1155/2011/656523

1 reference

Europe PubMed Central

12 September 2017

release_jfqujyqwajf7riiljnharkwtn4

0 references

1 reference

Europe PubMed Central

12 September 2017

1 reference

Europe PubMed Central

12 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39519018&oldid=1833916142"